Keensight Capital acquires majority stake in Isto Biologics, a leading orthobiologics player, from Thompson Street Capital Partners
                
                  
                    
                  
                  
                    
                      
                        
                      
                      
                    
                
              
            
Keensight Capital acquires majority stake in Isto Biologics, a leading orthobiologics player, from Thompson Street Capital Partners
                    
                      Sep 17, 2025 9:08:36 AM
                      
  
  
  3
 min read
                    
                  
                Isto Biologics Elevates Biologic Innovations Through Merger with Advanced Biologics/Biologica Technologies
                
                  
                    
                  
                  
                    
                      
                        
                      
                      
                    
                
              
            .png)
Isto Biologics Elevates Biologic Innovations Through Merger with Advanced Biologics/Biologica Technologies
                    
                      Oct 18, 2023 2:15:00 PM
                      
  
  
  2
 min read
                    
                  
                Isto Biologics Launches Influx™ Fibrant, a New Line of Advanced Allograft
                
                  
                    
                  
                  
                    
                      
                        
                      
                      
                    
                
              
            
Isto Biologics Launches Influx™ Fibrant, a New Line of Advanced Allograft
                    
                      Jun 21, 2022 1:15:00 PM
                      
  
  
  2
 min read
                    
                  